// App-Quantinova.ai

DMT55 : A Systematic Literature Review of Immunoglobulin Levels Among B-Cell–Depleting Therapies and Risk of Infections in Relapsing Multiple Sclerosis

Researchers

Presenter

  • Shiv Saidha

Principal Investigators

  • Judith Bell

  • Sydney Harold

  • Jose Marcano Belisario

  • Emma Hawe

  • Qiujun Shao

  • Kerri Wyse

  • Eric M. Maiese

Medical Centers

  • Dept. of Neurology, Johns Hopkins School of Medicine, Baltimore, MD

Locations

  • United States

  • United Kingdom

Companies

  • Novartis AG

  • RTI Health Solutions

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • N/A

Drug/Treatment

  • Ocrelizumab

  • ofatumumab Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved